pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 322 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Marketed
    mirdametinib ODT
    Gomekli (mirdametinib)
    Neurofibromatoses Type I (Von Recklinghausen's Disease) SpringWorks Therapeutics Inc
  • Marketed
    mirvetuximab soravtansine
    Elahere (mirvetuximab soravtansine-gynx)
    Epithelial Ovarian Cancer ImmunoGen Inc
  • Marketed
    mitotane
    Lysodren (mitotane)
    Adrenocortical Carcinoma (Adrenal Cortex Cancer) Esteve Pharmaceuticals SA
  • Marketed
← prev
page 9 of 11
next →
131
Pain89
Neurology1
mitoxantrone hydrochloride
Mitoxantrone Hydrochloride
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
  • Marketed
    motixafortide acetate
    motixafortide acetate
    Metastatic Adenocarcinoma of The Pancreas$BLRX BioLineRx Ltd.
  • Marketed
    nadofaragene firadenovec
    Adstiladrin (nadofaragene firadenovec)
    Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B… Ferring Pharmaceuticals Inc
  • Marketed
    necitumumab
    Portrazza (necitumumab)
    Squamous Non-Small Cell Lung Cancer Eli Lilly and Co
  • Marketed
    neratinib
    Nerlynx (neratinib)
    Metastatic Brain Tumor$PBYI PUMA BIOTECHNOLOGY, INC.
  • Marketed
    nilutamide
    Nilutamide Prasco (nilutamide)
    Metastatic Prostate Cancer Prasco LLC
  • Marketed
    olutasidenib
    Rezlidhia (olutasidenib)
    Refractory Acute Myeloid Leukemia$RIGL RIGEL PHARMACEUTICALS INC
  • Marketed
    omacetaxine mepesuccinate
    omacetaxine mepesuccinate
    Myelodysplastic Syndrome (Preleukemia)$TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
  • Marketed
    omeprazole magnesium DR
    Omeprazole Magnesium
    Systemic Mastocytosis Perrigo Pharmaceuticals Company (Inactive)
  • Marketed
    osimertinib mesylate
    Tagrisso (osimertinib mesylate)
    Non-Small Cell Lung Cancer$AZN ASTRAZENECA PLC
  • Marketed
    paclitaxel albumin bound
    Abraxane (paclitaxel)
    Non-Small Cell Lung Cancer Celgene Corp
  • Marketed
    palbociclib
    Ibrance (palbociclib)
    Breast Cancer$OTLC Oncotelic Therapeutics, Inc.
  • Marketed
    pamidronate disodium
    Pamidronate Disodium
    Osteolytic Lesion Areva Pharmaceuticals Inc
  • Marketed
    panitumumab
    Vectibix (panitumumab)
    Metastatic Colorectal Cancer$AMGN AMGEN INC
  • Marketed
    pazopanib hydrochloride
    Pazopanib Hydrochloride
    Renal Cell Carcinoma Novugen Pharma (Malaysia) Sdn Bhd
  • Marketed
    pegaspargase
    Oncaspar (pegaspargase)
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk… Servier Pharmaceuticals LLC
  • Marketed
    pemetrexed
    Pemfexy (pemetrexed [INN])
    Malignant Pleural Mesothelioma Eagle Pharmaceuticals Inc
  • Marketed
    pemetrexed tromethamine
    Pemetrexed Ditromethamine (pemetrexed tromethamine)
    Malignant Pleural Mesothelioma Hospira Inc
  • Marketed
    pemigatinib
    Pemazyre (pemigatinib)
    Metastatic Bile Duct Cancer$INCY INCYTE CORP
  • Marketed
    penpulimab
    Penpulimab-Kcqx (penpulimab)
    Nasopharyngeal Cancer Akeso Inc
  • Marketed
    pertuzumab
    Perjeta (pertuzumab)
    Human Epidermal Growth Factor Receptor 2 Positive Breast… Genentech Inc
  • Marketed
    pexidartinib hydrochloride
    Turalio (pexidartinib hydrochloride)
    Tenosynovial Giant Cell Tumor Daiichi Sankyo Co Ltd
  • Marketed
    phenoxybenzamine hydrochloride
    Phenoxybenzamine Hydrochloride
    Pheochromocytoma Novitium Pharma LLC
  • Marketed
    pirtobrutinib
    Jaypirca (pirtobrutinib)
    Chronic Lymphocytic Leukemia (CLL) Eli Lilly and Co
  • Marketed
    ponatinib hydrochloride
    Iclusig (ponatinib hydrochloride)
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…$TAK TAKEDA PHARMACEUTICAL CO LTD
  • Marketed
    porfimer sodium
    Photofrin (porfimer sodium)
    Endobronchial Cancer Concordia Healthcare USA Inc
  • Marketed
    pralatrexate
    Folotyn (pralatrexate)
    Peripheral T-Cell Lymphomas (PTCL) Fresenius Kabi USA LLC